131 genetic-algorithm-computer "Integreat Norwegian Centre for Knowledge driven Machine Learning" Postdoctoral positions at University of Washington
Sort by
Refine Your Search
-
Position Summary The Foltz lab works at the intersection of translational immunology and computational biology. We study mechanisms of response and resistance to natural killer (NK) cell therapies
-
Experience in one of the following areas is desired: medicine/urology/oncology, genomics/genetics, analysis of inflammation/immune composition, pharmacology, biomarker characterization. Expertise/skills in
-
, genetic information, gender identity or expression, age, disability, or protected veteran status. Benefits Information A summary of benefits associated with this title/rank can be found at https://hr.uw.edu
-
research team. Our work focuses on craniofacial regeneration and distraction osteogenesis, using cutting-edge multi-omic approaches (single-cell and spatial transcriptomics, genetic and biochemical analysis
-
under supervision, with the goal of establishing an independent research program and career path. The postdoc will be based at the University of Washington – Seattle Campus. The preferred start date is
-
compensation associated with this position may include travel to national or international conferences, computing equipment, and fees associated with manuscript publications, if applicable. A summary of benefits
-
pulmonary vascular endothelial cells contributes to pulmonary vascular remodeling. Our current research program includes investigations into the role of hyperactive mTOR (mechanistic target of rapamycin) in
-
the cross-campus Astrobiology Program , and the postdoctoral scolar would be part of this broader interdisciplinary environment. We seek a postdoc who would make the most of available collaborative
-
Program , and the postdoctoral scolar would be part of this broader interdisciplinary environment. We seek a postdoc who would make the most of available collaborative opportunities. Responsibilities: Write
-
, tumor immunology organotypic in-vitro models, genetically engineered animal models and human tissues from clinical trials. All these approaches are brought to bear on impactful questions in tumor